Skip to main content
ABBV
NYSE Life Sciences

FDA Approves SKINVIVE by JUVÉDERM for Neck Lines, Expanding AbbVie's Aesthetics Portfolio

Reported by PR Newswire
Sentiment info
Positive
Importance info
7
Price
$221.98
Mkt Cap
$391.504B
52W Low
$181.73
52W High
$244.81
Market data snapshot near publication time

Summary

AbbVie's Allergan Aesthetics unit secured FDA approval for SKINVIVE by JUVÉDERM® to treat horizontal neck lines, including those from 'tech-neck.' This is the second indication for the hyaluronic acid injectable, which was previously approved for cheek smoothness. The approval provides a new, unique treatment option for neck wrinkles, bolstering AbbVie's presence in the aesthetic market.

At the time of this announcement, ABBV was trading at $221.98 on NYSE in the Life Sciences sector, with a market capitalization of approximately $391.5B. The 52-week trading range was $181.73 to $244.81. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

ABBV - Latest Insights

ABBV
Jun 16, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $221.98
Real-time Price: $221.72 info
Change: -$0.260 (-0.12%) info
Market Cap: $391.733B info
ABBV
Jun 02, 2026, 4:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $216.01
Real-time Price: $221.72 info
Change: +$5.71 (+3%) info
Market Cap: $391.733B info
ABBV
May 29, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $219.00
Real-time Price: $221.72 info
Change: +$2.72 (+1%) info
Market Cap: $391.733B info
ABBV
May 27, 2026, 6:18 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $214.19
Real-time Price: $221.72 info
Change: +$7.53 (+4%) info
Market Cap: $391.733B info
ABBV
May 22, 2026, 8:37 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $215.00
Real-time Price: $221.72 info
Change: +$6.72 (+3%) info
Market Cap: $391.733B info
ABBV
May 08, 2026, 12:31 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $200.95
Real-time Price: $221.72 info
Change: +$20.77 (+10%) info
Market Cap: $391.733B info
ABBV
May 08, 2026, 12:28 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $201.00
Real-time Price: $221.72 info
Change: +$20.72 (+10%) info
Market Cap: $391.733B info
ABBV
Apr 29, 2026, 7:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $197.04
Real-time Price: $221.72 info
Change: +$24.68 (+13%) info
Market Cap: $391.733B info
ABBV
Apr 29, 2026, 7:47 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $197.96
Real-time Price: $221.72 info
Change: +$23.76 (+12%) info
Market Cap: $391.733B info
ABBV
Apr 28, 2026, 9:36 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $198.01
Real-time Price: $221.72 info
Change: +$23.71 (+12%) info
Market Cap: $391.733B info